Clinical Trial: Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077681) titled 'Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar' on June 30.

Brief Summary: In a population of adult patients followed for Crohn's disease, who had previously agreed to replace Stelara(R) with a biosimilar of ustekinumab (Uzpruvo(R)) and were followed over a period of 12 months under usual medical practice conditions.

* Main objective: To assess the maintenance of the biosimilar of ustekinumab at 12 months without returning to the reference treatment

* Secondary objectives:

* To describe the factors associated with the maintenance of the biosimilar

* To evaluate the...